يحاول ذهب - حر
Heavy risks of weight-loss drugs
December 04, 2024
|Business Standard
The health issues and social stigma associated with weight gain push obese people to try every possible solution that can help them shed unwanted kilograms. Unfortunately, many of them struggle to lose weight even with a balanced diet and plenty of exercise. This sense of failure is hard to cope with, especially in a culture that offers shame in place of support. In the face of such despair, prescription drugs seem to hold out a promise of hope.
"Some financial analysts believe that the market for them could be worth as much as $200 billion globally by 2030...Ozempic and its successors look set to become one of the iconic and defining drugs of our time, on a par with the contraceptive pill and Prozac," writes Johann Hari in his new book Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight-Loss Drugs.
What makes the book worth reading is the author's openness to diverse perspectives. He is not a medical expert, so the information that he makes available is based on conversations with scientists, published studies, and his own experience of injecting himself with Ozempic.
Numerous Indians who were unfamiliar with the drug learned about it thanks to jewellery designer Maheep Kapoor on the Netflix show Fabulous Lives vs Bollywood Wives. She called out people who use Ozempic to lose weight quickly, leading to a shortage of the drug for diabetics. Her remarks also led to speculation around filmmaker Karan Johar's recent weight loss, who took to Instagram and stated, "Being healthy and eating well and reinventing the wheel of your nutrition! Aur Ozempic ko mile credit (And Ozempic gets the credit)?"
هذه القصة من طبعة December 04, 2024 من Business Standard.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Business Standard
Business Standard
Bharat Forge signs ₹300 cr contract under EP-VI norms for army, navy
Bharat Forge Limited (BFL) has secured defence contracts worth ₹3300 crore under the Emergency Procurement-VI (EP-VI) framework for supplying indigenous unmanned systems to the security forces.
1 min
January 17, 2026
Business Standard
Centre likely to adjust ₹968 cr withheld tax
Tax authorities are set to adjust around ₹967.52 crore withheld in connection with Tiger Global’s exit from Flipkart, following a Supreme Court ruling that asked the US-based investor to pay around 214,500 crore in taxes, according to senior Central Board of Direct Taxes (CBDT) officials.
2 mins
January 17, 2026
Business Standard
Pakistan se azaadi
Pakistan not only has zero chance of catching up with India in most areas, but will inevitably see the gap rising. Its leaders will offer its people the same snake oil in different bottles
5 mins
January 17, 2026
Business Standard
Foreign investors’ interest in GIFT City may increase
India’s International Financial Services Centre (IFSC) at GIFT City in Gujarat could see higher interest from foreign investors as they reassess offshore structures after the Supreme Court’s Tiger Global ruling.
2 mins
January 17, 2026
Business Standard
Best suited for first-time equity investors seeking broad market exposure
Flexicap funds saw the sharpest rise in assets under management (AUM) among equity-oriented schemes in 2025.
2 mins
January 17, 2026
Business Standard
Reliance Retail reports 9.2% jump in operational revenue
Reliance Retail Ventures Ltd (RRVL) on Friday reported a 2.1 per cent year-on-year rise in net profit at ₹3,558 crore for the third quarter of 2025-26 (FY26).
1 mins
January 17, 2026
Business Standard
EPFO may employ third-party agents to resolve member grievances, queries
The Employees’ Provident Fund Organisation (EPFO) is likely to empanel third-party agents to help resolve queries and grievances of members, said two officials aware of the matter.
2 mins
January 17, 2026
Business Standard
Here comes the Sun-dance
Two short films set in South India will premiere at the largest independent film festival in the US. The debutant directors talk about their first steps into filmmaking
4 mins
January 17, 2026
Business Standard
SAT sets aside Sebi order on Bombay Dyeing, promoters
The Securities Appellate Tribunal (SAT) has set aside the Securities and Exchange Board of India’s (Sebi’s) October 2022 order against Bombay Dyeing and Manufacturing Company (BDMCL), and its promoters Nusli Wadia and sons Ness and Jehangir.
1 min
January 17, 2026
Business Standard
Margin pressures drag down RIL’s profit to 4-qtr low
Retail, oil & gas divisions remain laggards
3 mins
January 17, 2026
Listen
Translate
Change font size
